Eli Lilly and Company (NYSE: LLY) said the U.S. Food and Drug Administration approved Mounjaro (tirzepatide) to reduce the risk ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE